WELCOME | REGULAR SUBMISSION | LATE BREAKING SUBMISSION | CLINICAL CASE REPORT | TOPICS | ABSTRACT EMBARGO
Abstract SUBMISSION topics & KEYWORDS
Tracks A and B are subdivided into 27 abstract topics by disease:
- Antiphospholipid syndrome
- Autoinflammatory diseases, Vexas and other monogenic diseases
- Behcet's disease
- COVID-19
- Crystal related disorders
- Pain in rheumatic diseases, including fibromyalgia
- Immunodeficiency
- Infection-related rheumatic diseases
- Inflammatory arthritis
- Inflammatory myopathies
- Juvenile idiopathic arthritis
- Metabolic bone diseases and osteoporosis
- Mixed connective tissue disease
- Osteoarthritis and other mechanical musculoskeletal problems
- Other connective tissue diseases
- Psoriatic arthritis
- Rheumatoid arthritis
- Sarcoidosis
- Sjὅgren's syndrome
- Spondyloarthritis
- Systemic lupus erythematosus
- Systemic sclerosis
- Vasculitis, small and medium size vessels
- Vasculitis, large vessels including polymyalgia rheumatica
- Public health
- Other diseases
- Across diseases
HPR Track (C) is subdivided into the following categories:
28. HPR Measuring health
29. HPR Epidemiology and public health
30. HPR Interventions
31. HPR Patients' perspectives
32. HPR Implementation and service evaluation
33. HPR Professional education, training and competencies
PARE Track (D) is subdivided into the following categories:
34. Patient information and education
35. Building patient led organisations
36. Arthritis research
37. Innovations in arthritis health care
38. Psychosocial support
39. Work and rehabilitation
40. Best practice campaigning
PAED Track (E) covers all diseases (no subcategories).
Keywords are words or phrases that are relevant to the content of your abstract and specifically define your research work:
- Adaptive immunity
- Analgesics
- Animal Models
- Anti-Inflammatory Agents, Non-Steroidal
- Artificial Intelligence
- Atherosclerosis
- Autoantibodies
- Best practices
- biological DMARD
- Biomarkers
- Biosimilar Pharmaceuticals
- Bone
- Campaigning
- Cardiovascular diseases
- Cartilage
- Clinical Trial
- Cognitive Function
- Comorbidities
- Cytokines and Chemokines
- Descriptive Studies
- Diagnostic test
- Diet and Nutrition
- Digital health/Measuring health
- Disease-modifying Drugs (DMARDs)
- Economics
- Education
- Enthesitis
- Epidemiology
- Epigenetics
- Ethics
- Fibroblasts
- Gastrointestinal tract
- Genetics
- Geographical differences
- Glucocorticoids
- Health services research
- Heart
- Imaging
- Innate immunity
- Interdisciplinary research
- Investor initiated trial
- Kidneys
- Lifestyles
- Lungs
- Magnetic Resonance Imaging
- Malignancy
- Mental health
- Microbiome
- Motor function
- Non-pharmacological interventions
- Nursing
- Observational studies / registry
- Occupational therapy
- -omics
- Outcome measures
- Pain
- Patient information and education
- Patient organizations
- Patient Reported Outcome Measures
- Patient-led research
- Physical therapy/Physiotherapy
- Pregnancy and reproduction
- Prognostic factors
- Psychology
- Public health
- Qualitative research
- Quality of care
- Quality of life
- Randomized controlled trial
- Rare/orphan diseases
- Real-world evidence
- Registries
- Rehabilitation
- Remission
- Safety
- Sarcopenia
- Self-management
- Sex/gender/diversity
- Skin
- Social work
- Synovium
- Systematic review
- Tapering
- Targeted synthetic drugs
- Telemedicine
- Ultrasound
- Uveitis
- Vaccination/Immunization
- Validation
- Vitamin D
- Work-related issues
